Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours
Year: 2010
Type: article
Study design: Clinical Trial
Authors: Phillip G. Claringbold, Paul A. Brayshaw, Richard A. Price, J. Harvey Turner
Institutions: Fremantle Hospital, The University of Western Australia
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: 177Lu-octreotate, capecitabine, neuroendocrine tumors, metastatic neuroendocrine tumors, peptide receptor radionuclide therapy, radiosensitizing chemotherapy, combination therapy, objective response rate, progression-free survival, overall survival, myelosuppression, nephrotoxicity, radiation dosimetry
Open Access status: closed
OpenAlex ID: W1988986189
